The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is an immune-mediated inflammatory condition causing inflammation of gastrointestinal and systemic cells, with an increasing prevalence worldwide. Many factors are known to trigger and maintain inflammation in IBD including the innate and adaptive immune systems, gen...
Main Authors: | Grainne Holleran, Loris Lopetuso, Valentina Petito, Cristina Graziani, Gianluca Ianiro, Deirdre McNamara, Antonio Gasbarrini, Franco Scaldaferri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/10/2020 |
Similar Items
-
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease
by: Giorgia Colombo, et al.
Published: (2023-02-01) -
Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions
by: Lorena Ortega Moreno, et al.
Published: (2021-08-01) -
Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
by: Marcin Sochal, et al.
Published: (2021-10-01) -
Gold Nanoparticles Modulate BCG-Induced Innate Immune Memory in Human Monocytes by Shifting the Memory Response towards Tolerance
by: Benjamin J. Swartzwelter, et al.
Published: (2020-01-01) -
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study
by: Ivan Guerra, et al.
Published: (2023-01-01)